← Back to Search

Other

Test Oral Spray for Xerostomia

N/A
Waitlist Available
Research Sponsored by You First Services
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9 weeks
Awards & highlights

Study Summary

During routine clinical practice, it is observed that patients with suspected obstructive sleep apnea (OSA) often reported waking up with a dry mouth during the night or in the morning. This 9 week, cross-over group, randomized, single center, study will evaluate the efficacy of a proprietary formulation in comforting dry mouth in Sleep Apnea patients.

Eligible Conditions
  • Xerostomia
  • Dry Mouth
  • Obstructive Sleep Apnea
  • Sleep Apnea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Relief from dry mouth survey using questionnaires.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Test Oral SprayExperimental Treatment1 Intervention
Subjects will be instructed to mouth spray with 0.3 ml ( 2 sprays to the mouth) of their assigned mouth spray, 2 times daily (morning and evening), using only the assigned mouth spray provided for the 4 week duration of the study.
Group II: Placebo Oral SprayPlacebo Group1 Intervention
Subjects will be instructed to mouth spray with 0.3 ml ( 2 sprays to the mouth) of their placebo mouth spray, 2 times daily (morning and evening), for the 4 week duration of the study.

Find a Location

Who is running the clinical trial?

You First ServicesLead Sponsor
4 Previous Clinical Trials
170 Total Patients Enrolled
2 Trials studying Xerostomia
56 Patients Enrolled for Xerostomia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025